BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31192862)

  • 21. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
    Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
    Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
    Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract.
    Strong DW; Pearse HD
    Cancer; 1976 Nov; 38(5):2173-83. PubMed ID: 991130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ureteral stump after nephroureterectomy.
    Strong DW; Pearse HD; Tank ES; Hodges CV
    J Urol; 1976 Jun; 115(6):654-5. PubMed ID: 940196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
    Gakis G; Schubert T; Alemozaffar M; Bellmunt J; Bochner BH; Boorjian SA; Daneshmand S; Huang WC; Kondo T; Konety BR; Laguna MP; Matin SF; Siefker-Radtke AO; Shariat SF; Stenzl A
    World J Urol; 2017 Mar; 35(3):327-335. PubMed ID: 27043218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
    Jeldres C; Sun M; Lughezzani G; Isbarn H; Shariat SF; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Cancer; 2010 Aug; 116(16):3774-84. PubMed ID: 20564085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?
    Sakano S; Inamoto T; Inoue R; Matsumoto H; Nagao K; Yamamoto Y; Azuma H; Matsuyama H
    Jpn J Clin Oncol; 2015 Oct; 45(10):968-72. PubMed ID: 26232447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retroperitoneoscopy-assisted total nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Matsui Y; Ohara H; Ichioka K; Terada N; Yoshimura K; Terai A; Arai Y
    Urology; 2002 Dec; 60(6):1010-5. PubMed ID: 12475659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Bossuyt V; Provenzano E; Symmans WF; Webster F; Allison KH; Dang C; Gobbi H; Kulka J; Lakhani SR; Moriya T; Quinn CM; Sapino A; Schnitt S; Sibbering DM; Slodkowska E; Yang W; Tan PH; Ellis I
    Histopathology; 2024 Jun; 84(7):1111-1129. PubMed ID: 38443320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardized and Simplified Retroperitoneal Lymph Node Dissection During Retroperitoneal Laparoscopic Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Ureter or Renal Pelvis: En Bloc Resection Technique.
    Kanno T; Kobori G; Kubota M; Funada S; Haitani T; Okada T; Higashi Y; Moroi S; Yamada H
    Urology; 2018 Feb; 112():85-91. PubMed ID: 29158173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.
    Seisen T; Nison L; Remzi M; Klatte T; Mathieu R; Lucca I; Bozzini G; Capitanio U; Novara G; Cussenot O; Compérat E; Renard-Penna R; Peyronnet B; Merseburger AS; Fritsche HM; Hora M; Shariat SF; Colin P; Rouprêt M
    J Urol; 2016 May; 195(5):1354-1361. PubMed ID: 26612196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
    Zigeuner R; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Weizer A; Kikuchi E; Remzi M; Raman JD; Bolenz C; Bensalah K; Capitanio U; Koppie TM; Kassouf W; Sircar K; Patard JJ; Fernández MI; Wood CG; Montorsi F; Ströbel P; Wheat JC; Haitel A; Oya M; Guo CC; Ng C; Chade DC; Sagalowsky A; Langner C
    Eur Urol; 2010 Apr; 57(4):575-81. PubMed ID: 19959276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologic outcomes and survival in pT0 tumors after radical nephroureterectomy for upper tract urothelial carcinoma: results from of a large multicenter international collaborative study.
    Rouprêt M; Xylinas E; Colin P; Kluth L; Karakiewicz P; Shariat SF
    Eur Urol; 2013 Feb; 63(2):404-5. PubMed ID: 23040206
    [No Abstract]   [Full Text] [Related]  

  • 38. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and prognostic factors for renal parenchymal, pelvis, and ureter cancers in SEER registries: collaborative stage data collection system, version 2.
    Altekruse SF; Dickie L; Wu XC; Hsieh MC; Wu M; Lee R; Delacroix S
    Cancer; 2014 Dec; 120 Suppl 23(0 23):3826-35. PubMed ID: 25412394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases.
    Olgac S; Mazumdar M; Dalbagni G; Reuter VE
    Am J Surg Pathol; 2004 Dec; 28(12):1545-52. PubMed ID: 15577672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.